Wendy Sol

Leiden University Medical Center — Netherlands

Medicine · Health Sciences

17h-index2.0kcitations87works1.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

PARP inhibition in cancer therapy(36), DNA Repair Mechanisms(15), CRISPR and Genetic Engineering(9), Gene expression and cancer classification(9), Molecular Biology Techniques and Applications(8)

Publications87 total

A Bypass Flow Model to Study Endothelial Cell Mechanotransduction across Diverse Flow Environments
Journal of the American Society of Nephrology·2024
A bypass flow model to study endothelial cell mechanotransduction across diverse flow environments
Materials Today Bio·2024· 1 citedOpen Access
Fasting mimicking diet in diabetic mice partially preserves glomerular endothelial glycocalyx coverage, without changing the diabetic metabolic environment
American Journal of Physiology-Renal Physiology·2024· 4 citedOpen Access
Heart and kidney organoids maintain organ-specific function in a microfluidic system
Materials Today Bio·2023· 36 citedOpen Access
Multi-omics analysis reveals distinct non-reversion mechanisms of PARPi resistance in BRCA1- versus BRCA2-deficient mammary tumors
Cell Reports·2023· 38 citedOpen Access
Supplementary Figure 1 from Lack of ABCG2 Shortens Latency of BRCA1-Deficient Mammary Tumors and This Is Not Affected by Genistein or Resveratrol
2023Open Access
Data from Lack of ABCG2 Shortens Latency of BRCA1-Deficient Mammary Tumors and This Is Not Affected by Genistein or Resveratrol
2023Open Access
Supplementary Figure 1 from Lack of ABCG2 Shortens Latency of BRCA1-Deficient Mammary Tumors and This Is Not Affected by Genistein or Resveratrol
2023Open Access
Supplementary Figure Legends 1-10 from Loss of 53BP1 Causes PARP Inhibitor Resistance in <i>Brca1</i>-Mutated Mouse Mammary Tumors
2023Open Access
Supplementary Figures 1-10 from Loss of 53BP1 Causes PARP Inhibitor Resistance in <i>Brca1</i>-Mutated Mouse Mammary Tumors
2023Open Access
Supplementary Figure Legends 1-10 from Loss of 53BP1 Causes PARP Inhibitor Resistance in <i>Brca1</i>-Mutated Mouse Mammary Tumors
2023Open Access
Supplementary Figures 1-10 from Loss of 53BP1 Causes PARP Inhibitor Resistance in <i>Brca1</i>-Mutated Mouse Mammary Tumors
2023Open Access
Data from Lack of ABCG2 Shortens Latency of BRCA1-Deficient Mammary Tumors and This Is Not Affected by Genistein or Resveratrol
2023Open Access
Data from Loss of 53BP1 Causes PARP Inhibitor Resistance in <i>Brca1</i>-Mutated Mouse Mammary Tumors
2023Open Access
Supplementary Tables 1-2 from Loss of 53BP1 Causes PARP Inhibitor Resistance in <i>Brca1</i>-Mutated Mouse Mammary Tumors
2023Open Access
Data from Loss of 53BP1 Causes PARP Inhibitor Resistance in <i>Brca1</i>-Mutated Mouse Mammary Tumors
2023Open Access
Supplementary Tables 1-2 from Loss of 53BP1 Causes PARP Inhibitor Resistance in <i>Brca1</i>-Mutated Mouse Mammary Tumors
2023Open Access
Figure S6 from Radiosensitivity Is an Acquired Vulnerability of PARPi-Resistant BRCA1-Deficient Tumors
2023Open Access
Figure S2 from Radiosensitivity Is an Acquired Vulnerability of PARPi-Resistant BRCA1-Deficient Tumors
2023Open Access
Figure S5 from Radiosensitivity Is an Acquired Vulnerability of PARPi-Resistant BRCA1-Deficient Tumors
2023Open Access
page 1 of 5Next →

Frequent Co-authors

Sven Rottenberg(33), Jos Jonkers(32), Ariena Kersbergen(28), Piet Borst(19), Bernard M. van den Berg(15), Ton J. Rabelink(14), Marco Barazas(13), Alessia Gasparini(12), Aslι Küçükosmanoğlu(12), Marieke van de Ven(12), Gerben R. Borst(12), Peter Bouwman(11), Janneke E. Jaspers(11), Serge A.L. Zander(11), Gangqi Wang(11), Lodewyk F.A. Wessels(11), Stefano Annunziato(10), Natalie Proost(10), Renske de Korte‐Grimmerink(9), Anton Jan van Zonneveld(8)